Toshihide Kashihara Selected Research

Toshihide Kashihara Research Topics

Disease

10	Heart Failure 01/2022 - 01/2011
4	Ventricular Tachycardia 01/2020 - 01/2011
3	Ventricular Premature Complexes (Premature Ventricular Contraction) 01/2014 - 01/2011
2	Cardiomegaly (Heart Hypertrophy) 01/2022 - 03/2011
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 01/2019
2	Fibrosis (Cirrhosis) 01/2014 - 01/2012
2	Cardiac Arrhythmias (Arrythmia) 01/2014 - 01/2012
1	Diabetic Cardiomyopathies 01/2021
1	Hypertension (High Blood Pressure) 01/2019
1	Neuralgia (Stump Neuralgia) 01/2019
1	Pain (Aches) 01/2019
1	Thrombosis (Thrombus) 01/2019
1	Chronic Renal Insufficiency 01/2019
1	Atherosclerosis 01/2018
1	Myocardial Infarction 04/2015
1	Infarction (Infarctions) 04/2015
1	Ischemia 01/2014
1	Hypertrophy 01/2014
1	Timothy syndrome 06/2012
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2012
1	Tachycardia (Tachyarrhythmias) 01/2011

Drug/Important Bio-Agent (IBA)

3	Polyvinyl Chloride (PVC)IBA 01/2014 - 01/2011
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2012
2	ArrestinIBA 11/2020 - 01/2017
2	Angiotensin IIIBA 01/2019 - 01/2014
2	Sulfoglycosphingolipids (Sulfatides)IBA 01/2019 - 01/2019
2	Adrenergic Agents (Adrenergic Drugs)IBA 02/2014 - 03/2011
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 04/2012 - 03/2011
1	Serine (L-Serine)FDA Link 01/2022
1	Aspartic Acid (Aspartate)FDA Link 01/2022
1	GTP-Binding Proteins (G-Protein)IBA 01/2022
1	malic acid (malate)IBA 01/2022
1	AntioxidantsIBA 01/2021
1	Sar-Arg-Val-Tyr-Ile-His-Pro-Ala-OHIBA 11/2020
1	Pharmaceutical PreparationsIBA 11/2020
1	GlycosphingolipidsIBA 01/2019
1	Lipoproteins (Lipoprotein)IBA 01/2019
1	ProstaglandinsIBA 01/2019
1	Antihypertensive Agents (Antihypertensives)IBA 01/2019
1	Analgesics (Analgesic Drugs)IBA 01/2019
1	IvabradineIBA 01/2019
1	grapiprantIBA 01/2019
1	Platelet-Derived Growth FactorIBA 01/2018
1	CytokinesIBA 01/2018
1	Coloring Agents (Dyes)IBA 04/2015
1	Cholinergic Agents (Cholinergics)IBA 02/2014
1	Atropine FDA LinkGeneric 02/2014
1	1,3-dipropyl-8-cyclopentylxanthineIBA 02/2014
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 02/2014
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 02/2014
1	Type 1 Angiotensin ReceptorIBA 01/2014
1	PhlorhizinIBA 01/2014
1	olmesartanIBA 01/2014
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 02/2013
1	1,4-dihydropyridine (dihydropyridine)IBA 06/2012
1	Nifedipine (Adalat)FDA LinkGeneric 06/2012
1	Nicorandil (SG 75)IBA 01/2012
1	Protein Kinases (Protein Kinase)IBA 03/2011
1	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 03/2011
1	Diacylglycerol KinaseIBA 01/2011

Therapy/Procedure

2	Transplantation 01/2020 - 04/2015
2	Therapeutics 01/2019 - 01/2017
1	Renal Dialysis (Hemodialysis) 01/2019
1	Nephrectomy 01/2019
1	Oral Administration 01/2019